Omalizumab for the Treatment of Atopic Dermatitis

Statistics

Case Reports

Omalizumab en el tratamiento de la dermatitis atópica

M.C. Fernández-Antón Martíneza,

Corresponding author

carmenfernandezanton@hotmail.com

Corresponding author.

, V. Leis-Dosilb, F. Alfageme-Roldánc, A. Paravisinia, S. Sánchez-Ramóna, R. Suárez Fernándeza

a Hospital General Universitario Gregorio Marañón, Madrid, Spain

b Hospital Infanta Sofía, Madrid, Spain

c Hospital del Sureste, Madrid, Spain

Read

15231

Times
was read the article

4001

Total PDF

11230

Total HTML

Share statistics

Article information

ISSN: 15782190
Original language: English

DOI:10.1016/j.adengl.2012.08.002

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 6	152	13	165
2025 5	450	52	502
2025 4	497	41	538
2025 3	395	38	433
2025 2	356	46	402
2025 1	348	39	387
2024 12	293	29	322
2024 11	242	64	306
2024 10	201	38	239
2024 9	173	32	205
2024 8	264	62	326
2024 7	275	53	328
2024 6	223	60	283
2024 5	224	51	275
2024 4	185	44	229
2024 3	198	28	226
2024 2	219	41	260
2024 1	165	37	202
2023 12	191	26	217
2023 11	208	35	243
2023 10	174	23	197
2023 9	135	32	167
2023 8	107	36	143
2023 7	129	52	181
2023 6	83	39	122
2023 5	91	40	131
2023 4	81	35	116
2023 3	72	24	96
2023 2	55	27	82
2023 1	56	43	99
2022 12	62	63	125
2022 11	31	32	63
2022 10	32	22	54
2022 9	27	33	60
2022 8	28	42	70
2022 7	26	32	58
2022 6	30	17	47
2022 5	82	56	138
2022 4	60	38	98
2022 3	73	60	133
2022 2	72	31	103
2022 1	68	48	116
2021 12	60	55	115
2021 11	72	49	121
2021 10	94	64	158
2021 9	70	51	121
2021 8	58	33	91
2021 7	70	44	114
2021 6	86	41	127
2021 5	66	42	108
2021 4	227	81	308
2021 3	98	42	140
2021 2	84	46	130
2021 1	60	32	92
2020 12	59	27	86
2020 11	38	20	58
2020 10	39	19	58
2020 9	39	17	56
2020 8	36	27	63
2020 7	40	17	57
2020 6	33	47	80
2020 5	38	28	66
2020 4	48	22	70
2020 3	34	28	62
2020 2	2	12	14
2020 1	0	16	16
2019 12	4	10	14
2019 11	0	2	2
2019 10	0	1	1
2019 9	4	4	8
2019 8	0	9	9
2019 7	0	8	8
2019 6	2	7	9
2019 5	0	12	12
2019 4	0	8	8
2019 3	2	11	13
2019 2	0	4	4
2019 1	2	2	4
2018 12	2	0	2
2018 11	1	0	1
2018 10	4	0	4
2018 9	2	0	2
2018 8	0	2	2
2018 7	0	1	1
2018 4	0	4	4
2018 3	5	1	6
2018 2	50	11	61
2018 1	65	10	75
2017 12	68	17	85
2017 11	53	15	68
2017 10	50	8	58
2017 9	56	38	94
2017 8	56	26	82
2017 7	52	22	74
2017 6	67	41	108
2017 5	67	34	101
2017 4	68	21	89
2017 3	58	36	94
2017 2	42	23	65
2017 1	54	24	78
2016 12	55	33	88
2016 11	114	35	149
2016 10	93	31	124
2016 9	137	24	161
2016 8	108	29	137
2016 7	45	23	68
2016 6	8	30	38
2016 5	4	29	33
2016 4	7	9	16
2016 3	14	11	25
2016 2	12	14	26
2016 1	5	8	13
2015 12	4	9	13
2015 11	18	5	23
2015 10	13	12	25
2015 9	12	6	18
2015 8	15	10	25
2015 7	93	1	94
2015 6	70	20	90
2015 5	96	43	139
2015 4	80	31	111
2015 3	65	14	79
2015 2	57	23	80
2015 1	80	21	101
2014 12	66	23	89
2014 11	70	24	94
2014 10	81	38	119
2014 9	59	31	90
2014 8	40	10	50
2014 7	29	14	43
2014 6	42	12	54
2014 5	41	36	77
2014 4	37	12	49
2014 3	35	18	53
2014 2	27	20	47
2014 1	41	21	62
2013 12	26	18	44
2013 11	25	17	42
2013 10	22	19	41
2013 9	19	20	39
2013 8	21	39	60
2013 7	24	26	50
2013 6	15	27	42
2013 5	15	36	51
2013 4	26	24	50
2013 3	20	17	37
2013 2	31	9	40
2013 1	50	14	64
2012 12	30	14	44
2012 11	8	18	26
2012 10	4	25	29
2012 9	3	22	25

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter